Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient - Takeaways - MDSpire

Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient

  • By

  • Junyan Fang

  • Ruolin Li

  • Yingxin Xie

  • Yingli Liu

  • July 8, 2026

  • 0 min

Share

  • 1

    A 61-year-old man on peritoneal dialysis developed severe plaque psoriasis six years after starting treatment.

  • 2

    Initial management included topical corticosteroids and intensified dialysis, but psoriasis worsened significantly.

  • 3

    Secukinumab was administered at a dose of 300 mg weekly for four weeks, followed by maintenance doses every four weeks.

  • 4

    The patient achieved complete clearance of psoriatic lesions within four months, with no adverse events reported.

  • 5

    This case highlights the potential efficacy of secukinumab for treating severe psoriasis in patients undergoing peritoneal dialysis.

Original Source(s)

Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient

  • by Junyan Fang, Ruolin Li, Yingxin Xie, Yingli Liu

  • July 8, 2026

Related Content

T helper 17 cells and group 3 innate lymphoid cells define a spectrum of psoriasis endotypes

Skin barrier dysfunction and correlation with the onset and progression of psoriasis

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial